Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
41.09
+0.84 (+2.09%)
Official Closing Price
Updated: 7:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
42
43
Next >
7 New ETFs To Consider if You Want To Play Today’s Top Trends
February 22, 2022
These recently-launched ETFs offer diversification as well as the opportunity to benefit from the emerging industries and trends.
Via
InvestorPlace
Holiday Over
February 22, 2022
China is busily avoiding taking sides between Ukraine and Russia.
Via
Talk Markets
Golden Cross Appears Before Bristol-Myers Squibb Investors
February 21, 2022
If history is any guide, there may be good fortune ahead for shares of Bristol-Myers Squibb (NYSE:BMY). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
Bristol Myers Q4 Revenue, FY22 Sales Outlook Lag Consensus
February 04, 2022
Bristol Myers Squibb & Co (NYSE: BMY) has posted
Via
Benzinga
Drug Giant Bristol-Myers Squibb Stock Sees Composite Rating Climb To 96
February 18, 2022
Bristol-Myers Squibb stock saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 94 the day before.
Via
Investor's Business Daily
Will Investors Notice Exciting Sign On Bristol-Myers Squibb's Chart?
February 18, 2022
If history is any guide, there may be good fortune ahead for shares of Bristol-Myers Squibb (NYSE:BMY). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO...
Via
Benzinga
Bristol Myers Shares Interim Data From Long-Term Study Of Zeposia In Ulcerative Colitis
February 17, 2022
Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term efficacy and safety...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...
Via
Benzinga
Bristol-Myers Squibb Whale Trades Spotted
February 16, 2022
Someone with a lot of money to spend has taken a bullish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Bristol Myers Squibb's Mavacamten Aces Late-Stage Trial In Cardiomyopathy
February 16, 2022
Bristol Myers Squibb Co's (NYSE: BMY) VALOR-HCM Phase 3 study evaluating mavacamten in adults with obstructive hypertrophic cardiomyopathy (obstructive HCM) met its...
Via
Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.
Via
InvestorPlace
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Bristol Myers Squibb Co (NYSE: BMY) and Exelixis Inc (NASDAQ: EXEL) announced two-year follow-up results from the Phase 3 CheckMate -9ER trial of Opdivo (...
Via
Benzinga
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Daily Report: Bristol - Myers Squibb (BMY)
February 11, 2022
Bristol's price per share was $66.50 as of yesterday's market close. One year ago its price was $59.99.
Via
Talk Markets
6 Companies That Recently Announced Large Buybacks
February 10, 2022
There are several ways that a company can return wealth to its shareholders. Price appreciation and dividends are the two most common ways, but there are other ways a company...
Via
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fate Therapeutics Inc (NASDAQ: FATE) and Century...
Via
Benzinga
Looking At Bristol-Myers Squibb's Recent Whale Trades
February 07, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 17 strange trades.
Via
Benzinga
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
February 04, 2022
The major indexes slashed weekly gains after Monday's follow-through day.
Via
Investor's Business Daily
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.
Via
InvestorPlace
Bristol Myers Squibb (BMY) Q4 Earnings Meet Estimates
February 04, 2022
Bristol Myers Squibb came out with quarterly earnings of $1.83 per share.
Via
Talk Markets
Bristol Myers Ekes Out Earnings Beat As Cancer Drugs Spur Growth
February 04, 2022
The best growth during the quarter came from a blood thinner, an anemia treatment and cancer drugs.
Via
Investor's Business Daily
Bristol-Myers Squibb: Q4 Earnings Insights
February 04, 2022
Bristol-Myers Squibb (NYSE:BMY) reported its Q4 earnings results on Friday, February 4, 2022 at 06:59 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
5 Stocks To Watch For February 4, 2022
February 04, 2022
Some of the stocks that may grab inve3stor focus today are: Wall Street expects Bristol-Myers Squibb Company (NYSE: BMY) to report quarterly earnings at $1.80 per share on revenue of $12.08 billion...
Via
Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.
Via
Benzinga
Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels
February 03, 2022
It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap...
Via
Talk Markets
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.